Company / Inventory
Kiniksa Pharmaceuticals International, plc Inventory History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$54.9M
FY2025
5-year range
$3.7M / $54.9M
FY2021-FY2025
Trend
+108.2%
vs FY2024
Sector context
#54 of 105
Health Care
What the data says
At $55M, Kiniksa Pharmaceuticals International, plc's inventory ranks #54 of 105 in the Health Care sector. Improved from $31M to $55M over the past 2 years.
Based on SEC 10-K filings.
$55M in FY2025 with a 3-year CAGR of +36.5%.
Improved from $31M to $55M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +36.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#54 of 105 in Health CareTop 51% of 105This company $54.9M Sector average $885.3M
▼
-93.8% below sector average
Key checks
Key Insights
- 3-year CAGR of +36.5%, indicating consistent growth.
- In FY2025, inventory increased 108.2% year-over-year.
- Ranks #54 out of 105 companies in the Health Care sector.
- Lowest inventory in the period was in FY2021.
Company context
Key Data Points
- Negative profit margin: -10.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $54.9M | +108.2% |
| FY2024 | $26.4M | -15.3% |
| FY2023 | $31.1M | +44.1% |
| FY2022 | $21.6M | +487.7% |
| FY2021 | $3.7M | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026